Favor 3 Europe Japan Trial

FAVOR III

The trial will investigate something something computation of fractional flow reserve (FFR) based on invasive coronary angiographic images and will evaluate something of intermediate coronary stenosis.


Trial period

•

2018 - 2026

Status

•

Follow-up

Inclusions

•

2000 Complete

Centers

•

43

Countries

•

13

Publications

•

3


MEDIA

PUBLICATIONS

EuroIntervention
12 citations

Repeatability and quality assessment of QFR in the FAVOR III Europe trial

Kristensen Sophie Kjerstein, Holm Marie Barbara, Maillard Luc, Råmunddal Truls, Guiducci Vincenzo, +12 more

EuroIntervention
10 citations

Repeatability and quality assessment of QFR in the FAVOR III Europe trial: the REPEAT-QFR study.

Kristensen Sophie Kjerstein, Holm Marie Barbara, Maillard Luc, Råmunddal Truls, Guiducci Vincenzo, +12 more

Lancet
136 citations

Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe)

Andersen Birgitte Krogsgaard, Sejr-Hansen Martin, Maillard Luc, Campo Gianluca, Råmunddal Truls, +29 more